CANCER RESEARCH TRAINING AND EDUCATION COORDINATION (CRTEC) ? ABSTRACT Karmanos Cancer Institute (KCI) provides extensive cancer research training and educational programs that span all career stages. Dr. Michele Cote (PSDR), Associate Center Director for Education, leads KCI?s CRTEC efforts. In addition to identification, promotion, and support of University-sponsored training activities, Dr. Cote (PSDR) coordinates the cancer-specific programs at KCI. With the support of CRTEC Education Advisory Council members, each with expertise in a particular field or window of training, Dr. Cote (PSDR) serves as the main point of contact for trainees across the career trajectory. A key component of the CRTEC is to evaluate the effectiveness of the supported training activities, and identifying gaps and opportunities to enhance KCI training efforts across the spectrum. KCI?s education efforts span the education and training continuum including efforts focused on high school students, undergraduate students, graduate and medical students, post-doctoral trainees, residents and fellows, junior faculty, tenured faculty and community healthcare providers. CRTEC efforts are supported by ten active training projects totaling $895,210 direct costs. Several have grown out of a T32 led by Dr. Matherly (MT) (T32CA009531). This training program in the biology of cancer that has been continuously funded for over three decades. Since 2015, 24 students have been supported via the T32, five of whom were also awarded subsequent F30 or F31 support. Novel efforts at KCI include the launch of focuSStem in 2019, a program developed by a high school student, for high school students, with support from KCI leadership. In its inaugural year, five schools and 149 students have participated in the day-long program (37% African American, 30% non- Hispanic white, 27% Arab American, 4% Hispanic and 2% other races; over 50% females). A recent addition to our efforts in reaching high school students is the Discovery to Cure High School Internship Program (DTCHIP) (R25HD072591) led by Dr. Gil Mor (TBM) which will begin recruiting in the summer of 2020.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA022453-39
Application #
10088975
Study Section
Special Emphasis Panel (ZCA1)
Project Start
1997-08-08
Project End
2025-11-30
Budget Start
2020-12-15
Budget End
2021-11-30
Support Year
39
Fiscal Year
2021
Total Cost
Indirect Cost
Name
Wayne State University
Department
Type
DUNS #
001962224
City
Detroit
State
MI
Country
United States
Zip Code
48202
Herroon, Mackenzie K; Rajagurubandara, Erandi; Diedrich, Jonathan D et al. (2018) Adipocyte-activated oxidative and ER stress pathways promote tumor survival in bone via upregulation of Heme Oxygenase 1 and Survivin. Sci Rep 8:40
Colacino, Justin A; Azizi, Ebrahim; Brooks, Michael D et al. (2018) Heterogeneity of Human Breast Stem and Progenitor Cells as Revealed by Transcriptional Profiling. Stem Cell Reports 10:1596-1609
Blocker, Stephanie J; Shields, Anthony F (2018) Imaging of Nanoparticle Distribution to Assess Treatments That Alter Delivery. Mol Imaging Biol 20:340-351
Guastella, Anthony R; Michelhaugh, Sharon K; Klinger, Neil V et al. (2018) Investigation of the aryl hydrocarbon receptor and the intrinsic tumoral component of the kynurenine pathway of tryptophan metabolism in primary brain tumors. J Neurooncol 139:239-249
Li, Feng; Wang, Yongli; Li, Dapeng et al. (2018) Perspectives on the recent developments with green tea polyphenols in drug discovery. Expert Opin Drug Discov 13:643-660
Ramseyer, Vanesa D; Kimler, Victoria A; Granneman, James G (2018) Vacuolar protein sorting 13C is a novel lipid droplet protein that inhibits lipolysis in brown adipocytes. Mol Metab 7:57-70
Healy, Mark A; Morris, Arden M; Abrahamse, Paul et al. (2018) The accuracy of chemotherapy ascertainment among colorectal cancer patients in the surveillance, epidemiology, and end results registry program. BMC Cancer 18:481
Lacher, Sarah E; Alazizi, Adnan; Wang, Xuting et al. (2018) A hypermorphic antioxidant response element is associated with increased MS4A6A expression and Alzheimer's disease. Redox Biol 14:686-693
Alsaab, Hashem O; Sau, Samaresh; Alzhrani, Rami M et al. (2018) Tumor hypoxia directed multimodal nanotherapy for overcoming drug resistance in renal cell carcinoma and reprogramming macrophages. Biomaterials 183:280-294
Chammaa, May; Malysa, Agnes; Redondo, Carlos et al. (2018) RUMI is a novel negative prognostic marker and therapeutic target in non-small-cell lung cancer. J Cell Physiol 233:9548-9562

Showing the most recent 10 out of 826 publications